PharmAthene, Inc. (NYSE MKT: PIP) is a biodefense company engaged in the development and commercialization of next generation medical countermeasures against biological and chemical threats. The company’s biodefense portfolio includes product candidates SparVax®, a recombinant protective antigen anthrax vaccine, and Valortim®, a fully human monoclonal antibody for the prevention and treatment of anthrax infection. The company’s team is made up of seasoned, talented pharmaceutical, biotechnology and government contracting professionals. For more information, visit the company’s website at www.pharmathene.com.

Noble Financial Capital Markets, an equity research driven, full-service, investment banking boutique, is hosting its tenth annual equity conference in Sandpiper Bay, FL. Attended by institutional investors from across North America, the event features more than 140 public company executive teams from a diverse range of industries. For more information, visit www.noble.missionir.com.